✦ LIBER ✦

Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus

✍ Scribed by Laura Bracci; Irene Canini; Massimo Venditti; Massimo Spada; Simona Puzelli; Isabella Donatelli; Filippo Belardelli; Enrico Proietti

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Type I IFN is a powerful mucosal adjuvan

✍ Laura Bracci; Irene Canini; Simona Puzelli; Paola Sestili; Massimo Venditti; Mas 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 418 KB

Contrasting effects of type I interferon

✍ Robert B. Couch; Robert L. Atmar; Thomas R. Cate; John M. Quarles; Wendy A. Keit 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Inactivated meningococci and pertussis b

✍ Aud Katrine Herland Berstad; Svein Rune Andersen; Rolf Dalseg; Signe Drømtorp; J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 483 KB

A nasally administered trivalent inactiv

✍ J.M. Langley; F. Aoki; B.J. Ward; A. McGeer; J.B. Angel; G. Stiver; I. Gorfinkel 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Liposomes as a Mucosal Adjuvant System:

✍ Wilschut, J.; Haan, A. de; Geerligs, H. J.; Huchshorn, J. P.; van Scharrenburg, 📂 Article 📅 1994 🏛 Informa plc 🌐 English ⚖ 705 KB

Construction of CELO recombinant adenovi

✍ I. L. Tutykhina; M. I. Shul’pin; I. A. Chvala; M. M. Shmarov; D. Yu. Logunov; L. 📂 Article 📅 2011 🏛 Allerton Press, Inc. 🌐 English ⚖ 172 KB